TLR-8 antagonists (VentiRx Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTLR-8 antagonists (VentiRx Pharmaceuticals)
Drug Alias NameTLR-8 antagonist (VentiRx Pharmaceuticals)VTX-763
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 8 antagonists
TargetsToll like receptor 8
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAmerican Samoa
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVentirx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVentirx
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A